Getting Innovations to Patients During Shutdowns Act

Official title: To amend the Federal Food, Drug, and Cosmetic Act to establish special rules to provide for continued review of human drug and device submissions during a lapse of appropriations, and for other purposes.

1. house
3. senate
5. president

Introduced July 9, 2026 by Kevin Mullin · Last progress July 9, 2026